(This section applies only to the Wegovy® 7.2 mg dosing schedule.)
Wegovy® 7.2 mg is a higher weekly dose of semaglutide for adults who need additional weight-loss support beyond the standard Wegovy® 2.4 mg dose. It contains the same active ingredient as other Wegovy® strengths — the difference is the total weekly dose.
Overview
This article explains:
What Wegovy® 7.2 mg is
How Wegovy® 7.2 mg differs from Wegovy® 2.4 mg
Who may be eligible for the higher Wegovy® dose
How to take Wegovy® 7.2 mg safely
What to expect when using Wegovy® 7.2 mg
Use this guide if you have questions about your Wegovy® 7.2 mg treatment plan.
What is Wegovy® 7.2 mg?
Wegovy® 7.2 mg is a higher-dose version of semaglutide designed for people who:
Are already established on Wegovy® 2.4 mg
Need additional weight-loss support
Are tolerating Wegovy® well
It is not a new medicine — it is the same Wegovy® (semaglutide) at a higher weekly dose.
How Wegovy® 7.2 mg is currently given
At launch, Wegovy® 7.2 mg is delivered as:
Three separate 2.4 mg Wegovy® injections
Taken on the same day each week
This temporary approach is clinically approved until the single-dose Wegovy® 7.2 mg pen becomes available.
Effectiveness of Wegovy® 7.2 mg
In the STEP UP (Semaglutide Treatment Effect in People with obesity — Up-dose) clinical trial:
People taking Wegovy® 7.2 mg lost ~18.7% body weight
People taking Wegovy® 2.4 mg lost ~15.6%
This shows the higher Wegovy® dose may provide additional support for some patients.
Reference: Wharton S et al. Lancet Diabetes Endocrinol. 2025.
Who can move up to Wegovy® 7.2 mg?
The Wegovy® 7.2 mg dose may be considered for adults who:
Are already using Wegovy® 2.4 mg
Have tolerated the medication well
Need further weight-loss support
Your MedExpress prescriber will always decide whether moving to Wegovy® 7.2 mg is clinically appropriate.
Can I start Wegovy® at 7.2 mg?
No. All patients must start Wegovy® at the lowest dose (0.25 mg) and increase gradually.
This step-up approach:
Helps your body adjust
Reduces side-effect risk
Improves tolerability
Wegovy® 7.2 mg is only considered after stabilising on 2.4 mg.
Why have I received three Wegovy® pens?
At launch, Wegovy® 7.2 mg requires three 2.4 mg injections weekly.
This means:
You receive three Wegovy® pens per month
Each week you take one dose from each pen
One pen will not last the full month — this is expected
This setup is intentional, safe, and clinically approved.
Do the three Wegovy® injections need to be on the same day?
Yes. For Wegovy® 7.2 mg, you should:
Take all three injections
On the same day
Each week
Spacing them across the week is not recommended, as it may affect safety and effectiveness.
Injection site guidance for Wegovy® 7.2 mg
When taking the three weekly injections:
Use a new needle each time
Inject in the same body area if preferred
Place injections at least 5 cm apart
Rotate sites weekly to reduce irritation
What if I miss my Wegovy® 7.2 mg dose?
If you miss your Wegovy® dose:
Take it as soon as possible within 5 days
If more than 5 days have passed, skip and continue as normal
Do not take extra doses
Is Wegovy® 7.2 mg stronger than Mounjaro®?
Both treatments are highly effective but work differently:
Wegovy® (semaglutide) → GLP-1 receptor agonist
Mounjaro® (tirzepatide) → dual GIP + GLP-1 agonist
In clinical trials:
Wegovy® 7.2 mg → ~19% weight loss
Mounjaro® 15 mg → ~21% weight loss
The most suitable option depends on tolerability, response, and clinical assessment.
Key takeaway
Wegovy® 7.2 mg is a higher weekly dose of semaglutide for patients who need additional support beyond Wegovy® 2.4 mg. At launch, it is given as three 2.4 mg injections on the same day each week. Your MedExpress prescriber will determine whether this higher Wegovy® dose is appropriate for you.
If you still need help after reviewing the information above, additional assistance is available.